These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 27482699)

  • 1. Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors.
    Tsou PS; Wren JD; Amin MA; Schiopu E; Fox DA; Khanna D; Sawalha AH
    Arthritis Rheumatol; 2016 Dec; 68(12):2975-2985. PubMed ID: 27482699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Cysteine-Rich Angiogenic Inducer 61 as a Potential Antifibrotic and Proangiogenic Mediator in Scleroderma.
    Tsou PS; Khanna D; Sawalha AH
    Arthritis Rheumatol; 2019 Aug; 71(8):1350-1359. PubMed ID: 30884213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-Wide Reduction in Chromatin Accessibility and Unique Transcription Factor Footprints in Endothelial Cells and Fibroblasts in Scleroderma Skin.
    Tsou PS; Palisoc PJ; Ali M; Khanna D; Sawalha AH
    Arthritis Rheumatol; 2021 Aug; 73(8):1501-1513. PubMed ID: 33586346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells.
    Urbich C; Rössig L; Kaluza D; Potente M; Boeckel JN; Knau A; Diehl F; Geng JG; Hofmann WK; Zeiher AM; Dimmeler S
    Blood; 2009 May; 113(22):5669-79. PubMed ID: 19351956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features.
    Cipriani P; Di Benedetto P; Ruscitti P; Campese AF; Liakouli V; Carubbi F; Pantano I; Berardicurt O; Screpanti I; Giacomelli R
    Arthritis Res Ther; 2014 Sep; 16(5):442. PubMed ID: 25248297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells.
    Mazzotta C; Manetti M; Rosa I; Romano E; Blagojevic J; Bellando-Randone S; Bruni C; Lepri G; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M
    Arthritis Res Ther; 2017 Feb; 19(1):27. PubMed ID: 28183357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis.
    Ichimura Y; Asano Y; Akamata K; Noda S; Taniguchi T; Takahashi T; Toyama T; Tada Y; Sugaya M; Sato S; Kadono T
    Arthritis Rheumatol; 2015 Dec; 67(12):3245-55. PubMed ID: 26245842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines.
    Tsou PS; Rabquer BJ; Ohara RA; Stinson WA; Campbell PL; Amin MA; Balogh B; Zakhem G; Renauer PA; Lozier A; Arasu E; Haines GK; Kahaleh B; Schiopu E; Khanna D; Koch AE
    Rheumatology (Oxford); 2016 Apr; 55(4):745-54. PubMed ID: 26705326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
    Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the Cellular Mechanism of Prostacyclin Analog Iloprost in Reversing Vascular Dysfunction in Scleroderma.
    Tsou PS; Palisoc PJ; Flavahan NA; Khanna D
    Arthritis Rheumatol; 2021 Mar; 73(3):520-529. PubMed ID: 33001586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methyl-CpG-binding protein 2 mediates antifibrotic effects in scleroderma fibroblasts.
    He Y; Tsou PS; Khanna D; Sawalha AH
    Ann Rheum Dis; 2018 Aug; 77(8):1208-1218. PubMed ID: 29760157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma.
    Tsou PS; Campbell P; Amin MA; Coit P; Miller S; Fox DA; Khanna D; Sawalha AH
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3695-3702. PubMed ID: 30755532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.
    Mazzotta C; Romano E; Bruni C; Manetti M; Lepri G; Bellando-Randone S; Blagojevic J; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Arthritis Res Ther; 2015 Aug; 17(1):221. PubMed ID: 26292963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
    Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.
    Noda S; Asano Y; Takahashi T; Akamata K; Aozasa N; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    Rheumatology (Oxford); 2013 May; 52(5):790-9. PubMed ID: 23287360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone induced angiogenesis through the integrin αvβ3/protein kinase D/histone deacetylase 5 signaling pathway.
    Liu X; Zheng N; Shi YN; Yuan J; Li L
    J Mol Endocrinol; 2014 Jun; 52(3):245-54. PubMed ID: 24532656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell transcriptomes and chromatin accessibility of endothelial cells unravel transcription factors associated with dysregulated angiogenesis in systemic sclerosis.
    Huang M; Tabib T; Khanna D; Assassi S; Domsic R; Lafyatis R
    Ann Rheum Dis; 2024 May; ():. PubMed ID: 38754983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis.
    D'Alessio S; Fibbi G; Cinelli M; Guiducci S; Del Rosso A; Margheri F; Serratì S; Pucci M; Kahaleh B; Fan P; Annunziato F; Cosmi L; Liotta F; Matucci-Cerinic M; Del Rosso M
    Arthritis Rheum; 2004 Oct; 50(10):3275-85. PubMed ID: 15476218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study.
    Romano E; Bellando-Randone S; Manetti M; Bruni C; Lepri G; Matucci-Cerinic M; Guiducci S
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S148-52. PubMed ID: 26088817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis.
    Ha CH; Wang W; Jhun BS; Wong C; Hausser A; Pfizenmaier K; McKinsey TA; Olson EN; Jin ZG
    J Biol Chem; 2008 May; 283(21):14590-9. PubMed ID: 18332134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.